Healthcare firm Orbimed Asia will invest USD 42.5 million in Vivimed Labs's subsidiary UQUIFA. In an interview to CNBC-TV18, Santosh Varalwar, CMD of Vivimed Labs spoke at length about the same.
Pharmaceutical company, Vivimed Labs, has recently acquired Uquifa, a Spanish pharma company, for USD 55 million so as to expand business operations.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.